GENTleMEN: Genetic Testing for Men With Metastatic Prostate Cancer

Status: Recruiting
Location: See location...
Intervention Type: Other, Behavioral, Procedure
Study Type: Observational

This research study provides genetic testing to men with prostate cancer that has spread to other parts of the body (metastatic prostate cancer) and will look for inherited genetic mutations in about 30 cancer-risk genes. The researchers seek to learn about the participant's opinions and concerns about genetic testing, to determine if this is an acceptable way to deliver testing and to potentially help guide the participant's treatment. Neither treatment nor any decisions related to treatment will take place on this study, but researchers will share each participant's genetic testing results with that participant.

Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: No

• Signed informed consent form (ICF) providing agreement for germline genetic testing, use and release of health and research trial information

• Documented evidence of metastatic prostate cancer;

• Oncologist note within 4 months

• All computed tomography (CT), bone, positron emission tomography (PET) scan reports within 12 months

• All prostate-specific antigen (PSA) values within 12 months

• All available pathology reports from diagnosis, prostatectomy, and/or metastatic biopsy

• Willingness to provide basic demographic information, family cancer history, and treatment history

• Willingness and ability to complete patient reported outcomes questionnaire (on-line or hard copy) at enrollment, and at 6-month follow-up

• Willingness and ability to provide saliva sample

United States
Fred Hutch/University of Washington Cancer Consortium
Contact Information
Heather H. Cheng
Time Frame
Start Date: August 21, 2017
Estimated Completion Date: August 21, 2023
Target number of participants: 2000
Ancillary-Correlative (questionnaires, Color kit, counseling)
Participants receive web-based or hard-copy questionnaires and saliva collection kits via mail or in person. Participants also provide saliva samples to be mailed back to Color Genomics for genetic testing once complete. Participants then receive phone-based genetic counseling if they are identified to have an inherited mutation in a DNA repair gene. All participants have access to phone-based genetic counseling whether or not they are not found to have a mutation.
Related Therapeutic Areas
Leads: University of Washington
Collaborators: National Cancer Institute (NCI)

This content was sourced from

Similar Clinical Trials